311 related articles for article (PubMed ID: 20888013)
1. Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children.
McKamy S; Hernandez E; Jahng M; Moriwaki T; Deveikis A; Le J
J Pediatr; 2011 Mar; 158(3):422-6. PubMed ID: 20888013
[TBL] [Abstract][Full Text] [Related]
2. Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity.
Pritchard L; Baker C; Leggett J; Sehdev P; Brown A; Bayley KB
Am J Med; 2010 Dec; 123(12):1143-9. PubMed ID: 21183005
[TBL] [Abstract][Full Text] [Related]
3. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.
Cano EL; Haque NZ; Welch VL; Cely CM; Peyrani P; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; Kett DH;
Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995
[TBL] [Abstract][Full Text] [Related]
4. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.
Lodise TP; Patel N; Lomaestro BM; Rodvold KA; Drusano GL
Clin Infect Dis; 2009 Aug; 49(4):507-14. PubMed ID: 19586413
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin-associated acute kidney injury in pediatric cardiac intensive care patients.
Moffett BS; Hilvers PS; Dinh K; Arikan AA; Checchia P; Bronicki R
Congenit Heart Dis; 2015; 10(1):E6-10. PubMed ID: 24934335
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy.
Ingram PR; Lye DC; Tambyah PA; Goh WP; Tam VH; Fisher DA
J Antimicrob Chemother; 2008 Jul; 62(1):168-71. PubMed ID: 18334494
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin-induced acute kidney injury detected by a prospective pharmacovigilance program from laboratory signals.
Ramírez E; Jiménez C; Borobia AM; Tong HY; Medrano N; Krauel-Bidwell L; Carcas AJ; Selgas R; Frías J
Ther Drug Monit; 2013 Jun; 35(3):360-6. PubMed ID: 23666575
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam.
Burgess LD; Drew RH
Pharmacotherapy; 2014 Jul; 34(7):670-6. PubMed ID: 24855041
[TBL] [Abstract][Full Text] [Related]
9. High-dose intravenous vancomycin therapy and the risk of nephrotoxicity.
Rostas SE; Kubiak DW; Calderwood MS
Clin Ther; 2014 Jul; 36(7):1098-101. PubMed ID: 24931573
[TBL] [Abstract][Full Text] [Related]
10. Acute kidney injury during vancomycin therapy in critically ill children.
Totapally BR; Machado J; Lee H; Paredes A; Raszynski A
Pharmacotherapy; 2013 Jun; 33(6):598-602. PubMed ID: 23526674
[TBL] [Abstract][Full Text] [Related]
11. The Relationship of nephrotoxicity to vancomycin trough serum concentrations in a veteran's population: a retrospective analysis.
Horey A; Mergenhagen KA; Mattappallil A
Ann Pharmacother; 2012 Nov; 46(11):1477-83. PubMed ID: 23073306
[TBL] [Abstract][Full Text] [Related]
12. Risk of nephrotoxicity with combination vancomycin-aminoglycoside antibiotic therapy.
Pauly DJ; Musa DM; Lestico MR; Lindstrom MJ; Hetsko CM
Pharmacotherapy; 1990; 10(6):378-82. PubMed ID: 2287556
[TBL] [Abstract][Full Text] [Related]
13. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
Jeffres MN; Isakow W; Doherty JA; Micek ST; Kollef MH
Clin Ther; 2007 Jun; 29(6):1107-15. PubMed ID: 17692725
[TBL] [Abstract][Full Text] [Related]
14. Nephrotoxicity in patients with vancomycin trough concentrations of 15-20 μg/ml in a pediatric intensive care unit.
Cies JJ; Shankar V
Pharmacotherapy; 2013 Apr; 33(4):392-400. PubMed ID: 23471688
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections.
Hermsen ED; Hanson M; Sankaranarayanan J; Stoner JA; Florescu MC; Rupp ME
Expert Opin Drug Saf; 2010 Jan; 9(1):9-14. PubMed ID: 20021290
[TBL] [Abstract][Full Text] [Related]
16. A propensity-matched cohort study of vancomycin-associated nephrotoxicity in neonates.
Constance JE; Balch AH; Stockmann C; Linakis MW; Korgenski EK; Roberts JK; Ward RM; Sherwin CM; Spigarelli MG
Arch Dis Child Fetal Neonatal Ed; 2016 May; 101(3):F236-43. PubMed ID: 26400103
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis*.
Hanrahan TP; Harlow G; Hutchinson J; Dulhunty JM; Lipman J; Whitehouse T; Roberts JA
Crit Care Med; 2014 Dec; 42(12):2527-36. PubMed ID: 25083977
[TBL] [Abstract][Full Text] [Related]
18. Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study.
Matson KL; Shaffer CL; Beck GL; Simonsen KA
Pharmacotherapy; 2015 Mar; 35(3):337-43. PubMed ID: 25756622
[TBL] [Abstract][Full Text] [Related]
19. Impact of pharmacist intervention on preventing nephrotoxicity from vancomycin.
Masuda N; Maiguma T; Komoto A; Haruki Y; Sugiyama T; Kondo S; Teshima D
Int J Clin Pharmacol Ther; 2015 Apr; 53(4):284-91. PubMed ID: 25740266
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy.
Wong-Beringer A; Joo J; Tse E; Beringer P
Int J Antimicrob Agents; 2011 Feb; 37(2):95-101. PubMed ID: 21130609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
